Press Releases Verona Pharma plc London S.E.

Equities

VRP

GB00BYW2KH80

Delayed London S.E. Other stock markets 12:35:15 2020-10-29 pm EDT			5-day change	1st Jan Change
55 ^GBX	+5.77%		+4.76%	-11.29%

Apr. 22	European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	MT
Apr. 16	European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Verona Pharma : AGM 2024 Results	Apr. 26	PU
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update	Apr. 25	AQ
Verona Pharma : Notice and Proxy Statement AGM 2024	Mar. 21	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	Mar. 21	PU
Verona Pharma : Notice and Proxy Statement AGM 2024	Mar. 19	PU
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	Mar. 19	PU
Andrew Fisher Joins Verona Pharma as General Counsel	Mar. 04	AQ
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Feb. 29	AQ
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	Feb. 15	AQ
Michael Austwick Joins Verona Pharma as Non-Executive Director	Feb. 01	AQ
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital	Jan. 02	AQ
Verona Pharma : Change in Certifying Accountants - Form 8-K	Dec. 18	PU
Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP Award	Nov. 17	AQ
Verona Pharma Announces November 2023 Investor Conference Participation	Nov. 08	AQ
Verona Pharma : VRNA Investor Presentation November 2023	Nov. 06	PU
Verona Pharma : VRNA Presentation November 2023	Nov. 02	PU
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 02	AQ
Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update	23-10-19	AQ
Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023	23-10-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Verona Pharma plc London S.E.

Equities

VRP

GB00BYW2KH80

Press Releases

Filters